Department of Medical Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands.
Infect Control Hosp Epidemiol. 2011 Apr;32(4):333-41. doi: 10.1086/658941.
The objectives of this study were to determine the incidence density and the occurrence of horizontal spread of highly resistant gram-negative rods (HR-GNRs) in Dutch hospitals. The factors that influence these outcome measures were also investigated.
All patients with HR-GNRs, as determined by sample testing, who were hospitalized in 1 of 18 hospitals during a 6-month period (April through October 2007) were included in this study. For all available isolates, the species was identified, susceptibility was determined (including the presence of extended-spectrum β-lactamases [ESBLs]), and molecular typing was performed. On the basis of a combination of species identification, molecular typing, and epidemiological data, the occurrence of nosocomial transmission was determined.
The mean incidence density of patients with HR-GNRs was 55 per 100,000 patient-days (cumulative incidence, 39 per 10,000 patients admitted). A facility being a university hospital was a statistically significant (P = .03) independent determinant of a higher incidence of patients with HR-GNRs. The majority of HR-GNR isolates were ESBL producers. The adjusted transmission index-the ratio between secondary and primary cases-in the participating hospitals ranged from 0.0 to 0.2. The overall adjusted transmission index of HR-GNRs was 0.07. No determinants for a higher transmission index were identified.
The nosocomial transmission rate of HR-GNRs was relatively low in all hospitals where well-established transmission-based precautions were used. The incidence density of patients with HR-GNRs was higher in university hospitals, probably due to the patient population and the complexity of the care provided.
本研究旨在确定荷兰医院中高度耐革兰氏阴性菌(HR-GNR)的发生率密度和横向传播的发生情况。还研究了影响这些结果测量的因素。
在 6 个月(2007 年 4 月至 10 月)期间,将在 18 家医院之一住院且样本检测确定为 HR-GNR 的所有患者均纳入本研究。对所有可用的分离株进行了物种鉴定、药敏试验(包括是否存在超广谱β-内酰胺酶 [ESBL])和分子分型。根据物种鉴定、分子分型和流行病学数据的组合,确定了医院内传播的发生情况。
HR-GNR 患者的平均发生率密度为每 100,000 患者日 55 例(累积发生率为每 10,000 名入院患者 39 例)。医疗机构为大学医院是 HR-GNR 患者发病率较高的统计学显著(P =.03)独立决定因素。大多数 HR-GNR 分离株是 ESBL 生产者。参与医院的调整传播指数-继发病例与原发病例的比值-范围为 0.0 至 0.2。HR-GNR 的总体调整传播指数为 0.07。未确定更高传播指数的决定因素。
在所有使用既定基于传播的预防措施的医院中,HR-GNR 的医院内传播率相对较低。大学医院的 HR-GNR 患者发生率密度较高,可能是由于患者人群和所提供的护理的复杂性所致。